Naftali T - Search Results

1

The inflammatory bowel disease disk application: A platform to assess patients' priorities and expectations from treatment.

Naftali T, Richter V, Mari A, Khoury T, Shirin H, Broide E. Naftali T, et al. J Dig Dis. 2021 Oct;22(10):582-589. doi: 10.1111/1751-2980.13045. Epub 2021 Sep 21. J Dig Dis. 2021. PMID: 34431218

2

Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.

Naftali T, Novick D, Gabay G, Rubinstein M, Novis B. Naftali T, et al. Isr Med Assoc J. 2007 Jul;9(7):504-8. Isr Med Assoc J. 2007. PMID: 17710779 Free article.

3

False negative fecal occult blood test may be associated with increased mortality from colorectal cancer.

Half EE, Mlynarsky L, Naftali T, Benjaminov F, Konikoff FM. Half EE, et al. Among authors: naftali t. Dig Dis Sci. 2013 Sep;58(9):2639-45. doi: 10.1007/s10620-013-2702-1. Epub 2013 May 22. Dig Dis Sci. 2013. PMID: 23695870

4

Cannabis for inflammatory bowel disease.

Naftali T, Mechulam R, Lev LB, Konikoff FM. Naftali T, et al. Dig Dis. 2014;32(4):468-74. doi: 10.1159/000358155. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969296 Review.

5

Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.

Yablecovitch D, Stein A, Shabat-Simon M, Naftali T, Gabay G, Laish I, Oren A, Konikoff FM. Yablecovitch D, et al. Among authors: naftali t. Dig Dis Sci. 2015 Aug;60(8):2419-26. doi: 10.1007/s10620-015-3589-9. Epub 2015 Feb 22. Dig Dis Sci. 2015. PMID: 25702042

6

Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel disease.

Laish I, Katz H, Stein A, Liberman M, Naftali T, Kitay-Cohen Y, Biron-Shental T, Konikoff FM, Amiel A. Laish I, et al. Among authors: naftali t. Dig Liver Dis. 2015 Sep;47(9):790-6. doi: 10.1016/j.dld.2015.05.002. Epub 2015 May 13. Dig Liver Dis. 2015. PMID: 26048252

7

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Naftali T, Mechulam R, Marii A, Gabay G, Stein A, Bronshtain M, Laish I, Benjaminov F, Konikoff FM. Naftali T, et al. Dig Dis Sci. 2017 Jun;62(6):1615-1620. doi: 10.1007/s10620-017-4540-z. Epub 2017 Mar 27. Dig Dis Sci. 2017. PMID: 28349233 Clinical Trial.

8

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.

Lahat A, Shitrit AB, Naftali T, Milgrom Y, Elyakim R, Goldin E, Levhar N, Selinger L, Zuker T, Fudim E, Picard O, Yavzori M, Ben-Horin S. Lahat A, et al. Among authors: naftali t. J Crohns Colitis. 2018 Jan 5;12(1):120-123. doi: 10.1093/ecco-jcc/jjx120. J Crohns Colitis. 2018. PMID: 28961712

9

Revealing the Puzzle of Nonadherence in IBD-Assembling the Pieces.

Eindor-Abarbanel A, Naftali T, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Konikoff F, Matalon S, Shirin H, Milgrom Y, Broide E. Eindor-Abarbanel A, et al. Among authors: naftali t. Inflamm Bowel Dis. 2018 May 18;24(6):1352-1360. doi: 10.1093/ibd/izy013. Inflamm Bowel Dis. 2018. PMID: 29718228

10

Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study.

Ungar B, Engel T, Yablecovitch D, Lahat A, Lang A, Avidan B, Har-Noy O, Carter D, Levhar N, Selinger L, Neuman S, Natour OH, Yavzori M, Fudim E, Picard O, Kopylov U, Chowers Y, Naftali T, Broide E, Shachar E, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: naftali t. Am J Gastroenterol. 2018 Jun;113(6):890-898. doi: 10.1038/s41395-018-0073-0. Epub 2018 Jun 5. Am J Gastroenterol. 2018. PMID: 29867175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page